EGS manufactures EsophyX technology is used to reconstruct the gastroesophageal valve in the TIF 2.0 procedure.
Industries Health CareHealth DiagnosticsMedical DeviceHeadquarters Regions San Francisco Bay Area, Silicon Valley, West Coast Founded Date May 2003 Founders Jim Fitzsimmons, Scott J. Wolf, Stefan Kraemer Operating Status Active Last Funding Type Venture - Series Unknown Also Known As EsophyX, TIF procedure Legal Name EndoGastric Solutions, Inc.
Company Type For Profit
Contact Email info@endogastricsolutions.com Phone Number (425) 307-9200
EndoGastric Solutions, Inc. (www.endogastricsolutions.com), is a medical device company developing and commercializing innovative, evidence-based, incisionless surgical technology for the treatment of GERD. EGS has combined the most advanced concepts in gastroenterology and surgery to develop the Transoral Incisionless Fundoplication (TIF®) 2.0
procedure—a minimally invasive solution that addresses a significant unmet clinical need.
EndoGastric Solutions, Inc. was founded in 2003 and is headquartered in Redmond, Washington.